D
Diagnos Inc. ADK.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 6/21/2024Upgraded
Diagnos Inc. (ADK.V) was upgraded to D- from E+ on 6/21/2024 due to an increase in the volatility index and total return index.
E
Sell 5/31/2024Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D- on 5/31/2024 due to a decline in the volatility index.
D
Sell 5/15/2024Upgraded
Diagnos Inc. (ADK.V) was upgraded to D- from E+ on 5/15/2024 due to an increase in the volatility index and total return index.
E
Sell 4/26/2024Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D- on 4/26/2024 due to a decline in the volatility index and total return index.
D
Sell 4/11/2024Upgraded
Diagnos Inc. (ADK.V) was upgraded to D- from E+ on 4/11/2024 due to an increase in the volatility index.
E
Sell 3/21/2024Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D- on 3/21/2024 due to a substantial decline in the growth index, volatility index and solvency index. Operating cash flow declined 82.6% from -$262.7 to -$479.7, the quick ratio declined from 0.65 to 0.59, and EBIT declined 8.43% from -$460.2 to -$499.
D
Sell 3/14/2023Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 03/14/2023.
D
Sell 2/23/2023Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell 2/8/2023Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 2/8/2023 due to a significant decline in the solvency index.
D
Sell 5/16/2022Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and valuation index.
E
Sell 5/13/2022Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell 5/4/2022Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from E+ on 05/04/2022.
E
Sell 5/1/2022Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell 4/21/2022Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from E+ on 04/21/2022.
E
Sell 4/20/2022Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.33 to 1.63, and the quick ratio declined from 1.8 to 1.31.
D
Sell 11/9/2021Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from E+ on 11/09/2021.
E
Sell 11/8/2021Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index.
D
Sell 8/31/2020Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 8/31/2020 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.0192 to -$0.0058, operating cash flow increased 65.7% from -$873.3 to -$299.5, and EBIT increased 43.95% from -$807.9 to -$452.8.
D
Sell 6/5/2020Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 6/5/2020 due to a noticeable decline in the growth index, valuation index and volatility index. Operating cash flow declined 121.09% from -$395 to -$873.3, EBIT declined 103.5% from -$397 to -$807.9, and earnings per share declined from -$0.0101 to -$0.0192.
D
Sell 5/1/2020Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from E+ on 5/1/2020 due to an increase in the total return index and valuation index.
E
Sell 3/6/2020Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D on 3/6/2020 due to a decline in the growth index. Operating cash flow declined 66.32% from -$237.5 to -$395, and EBIT declined 0.4% from -$395.4 to -$397.
D
Sell 2/24/2020Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 2/24/2020 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.0245 to -$0.0103, operating cash flow increased 49.75% from -$472.6 to -$237.5, and EBIT increased 20.43% from -$496.9 to -$395.4.
D
Sell 9/30/2019Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 9/30/2019 due to a decline in the total return index and volatility index.
D
Sell 7/5/2019Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 7/5/2019 due to an increase in the growth index. Operating cash flow increased 62.75% from -$697.8 to -$259.9, earnings per share increased from -$0.0402 to -$0.0265, and EBIT increased 23.21% from -$572.7 to -$439.8.
D
Sell 2/28/2019Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 2/28/2019 due to a decline in the solvency index.
D
Sell 1/16/2019Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 1/16/2019 due to an increase in the volatility index and total return index.
D
Sell 12/31/2018Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 12/31/2018 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 520.71% from -$112 to -$695.2, total revenue declined 49.45% from $72.2 to $36.5, and EBIT declined 18.18% from -$560.6 to -$662.5.
D
Sell 9/13/2018Downgrade
Diagnos Inc. (ADK.V) was downgraded to D from D+ on 9/13/2018 due to a decline in the volatility index and solvency index.
D
Sell 8/29/2018Upgraded
Diagnos Inc. (ADK.V) was upgraded to D+ from D on 8/29/2018 due to a substantial increase in the growth index, total return index and volatility index. Operating cash flow increased 87.2% from -$874.7 to -$112, total revenue increased 37% from $52.7 to $72.2, and earnings per share increased from -$0.0048 to -$0.0043.
D
Sell 8/14/2018Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 8/14/2018 due to a large increase in the solvency index, growth index and valuation index.
D
Sell 7/6/2017Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 7/6/2017 due to a decline in the valuation index and solvency index.
D
Sell 6/21/2017Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 6/21/2017 due to a substantial increase in the total return index and volatility index.
D
Sell 11/17/2016Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 11/17/2016 due to a noticeable decline in the growth index, volatility index and total return index. EBIT declined 40.85% from -$428.4 to -$603.4, operating cash flow declined 29.2% from -$331.8 to -$428.7, and earnings per share declined from -$0.005 to -$0.006.
D
Sell 8/24/2016Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 8/24/2016 due to a noticeable increase in the growth index and volatility index. Total revenue increased 17.3% from $175.7 to $206.1, EBIT increased 9.04% from -$471 to -$428.4, and earnings per share increased from -$0.0054 to -$0.005.
D
Sell 7/18/2016Upgraded
Diagnos Inc. (ADK.V) was upgraded to D- from E+ on 7/18/2016 due to a significant increase in the solvency index, growth index and valuation index.
E
Sell 7/1/2016Downgrade
Diagnos Inc. (ADK.V) was downgraded to E+ from D- on 7/1/2016 due to a significant decline in the solvency index, growth index and valuation index. The quick ratio declined from 0.65 to 0.4.
D
Sell 3/11/2016Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 3/11/2016 due to a significant decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.09 to 0.65, and debt to equity increased from -2.22 to -1.51.
D
Sell 7/7/2015Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 7/7/2015 due to a major increase in the volatility index and total return index.
D
Sell 6/22/2015Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 6/22/2015 due to a large decline in the volatility index.
D
Sell 6/1/2015Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 6/1/2015 due to a large increase in the volatility index and total return index.
D
Sell 3/2/2015Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 3/2/2015 due to a decline in the valuation index.
D
Sell 2/13/2015Upgraded
Diagnos Inc. (ADK.V) was upgraded to D from D- on 2/13/2015 due to an increase in the valuation index.
D
Sell 1/29/2015Downgrade
Diagnos Inc. (ADK.V) was downgraded to D- from D on 1/29/2015 due to a large decline in the total return index, solvency index and growth index. Debt to equity increased from 0.85 to 2.16, operating cash flow declined 43.76% from -$946.3 to -$532.2, and EBIT declined 20.07% from -$675 to -$539.5.
Weiss Ratings